Zist Arvand Pharmed Company (DARVAND) cash flow statement
Operating, investing and financing cash flows, and the closing balance
- Ticker
- DARVAND
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 |
|---|---|---|
| Cash generated from operations | -4,174,444 | -196,819 |
| Cash payments for income tax | -216,000 | -232,928 |
| Net cash inflow (outflow) from operating activities | -4,390,444 | -429,747 |
| Cash payments for purchase of property, plant and equipment | -8,354,580 | -384,431 |
| Cash payments for purchase of intangible assets | -12,503 | -4,415 |
| Cash receipts from interest on other investments | 22,918 | 10,945 |
| Net cash inflow (outflow) from investing activities | -8,344,165 | -377,901 |
| Net cash inflow (outflow) before financing activities | -12,734,609 | -807,648 |
| Cash receipts from facilities | 31,207,171 | 5,582,834 |
| Cash payments for principal of loans | -15,538,699 | -3,341,620 |
| Cash payments for interest on loans | -2,721,674 | -655,687 |
| Net cash inflow (outflow) from financing activities | 12,946,798 | 1,585,527 |
| Net increase (decrease) in cash | 212,189 | 777,879 |
| Cash balance at beginning of year | 1,423,048 | 1,170,674 |
| Cash balance at end of year | 1,635,237 | 1,948,553 |
Reporting periods
9 periods are on file for this report, from the period ending 1400/12/29 to the period ending 1405/06/31.